Maxia Pharmaceuticals Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$28.3M
Maxia Pharmaceuticals General Information
Description
Provider of non-dermatological applications of a patented library of compounds. The company focuses on small molecule drugs that target major diseases such as cancer and metabolic disorders.
Contact Information
Corporate Office
- 10835 Altman Row
- Suite 250
- San Diego, CA 92121
- United States
Corporate Office
- 10835 Altman Row
- Suite 250
- San Diego, CA 92121
- United States
Maxia Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 19-Feb-2003 | $28.3M | Completed | Product Development | ||
| 2. Early Stage VC | 13-May-2002 | Completed | Product Development | |||
| 1. Early Stage VC (Series B) | 01-Jun-2000 | $20.5M | $20.5M | Completed | Generating Revenue |
Maxia Pharmaceuticals Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Maxia Pharmaceuticals Former Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Bay City Capital | Venture Capital | Minority | ||
| Ironbark Asset Management Fund Services | Other | Minority | ||
| Johnson & Johnson JJDC | Corporate Venture Capital | Minority | ||
| Orion Partners (Hong Kong) | Family Office | Minority | ||
| Rüd, Blass & Cie AG | Corporation | Minority |
Maxia Pharmaceuticals FAQs
-
Where is Maxia Pharmaceuticals headquartered?
Maxia Pharmaceuticals is headquartered in San Diego, CA.
-
What industry is Maxia Pharmaceuticals in?
Maxia Pharmaceuticals’s primary industry is Drug Discovery.
-
Is Maxia Pharmaceuticals a private or public company?
Maxia Pharmaceuticals is a Private company.
-
What is the current valuation of Maxia Pharmaceuticals?
The current valuation of Maxia Pharmaceuticals is .
-
What is Maxia Pharmaceuticals’s current revenue?
The current revenue for Maxia Pharmaceuticals is .
-
How much funding has Maxia Pharmaceuticals raised over time?
Maxia Pharmaceuticals has raised $28M.
-
Who are Maxia Pharmaceuticals’s investors?
Bay City Capital, Ironbark Asset Management Fund Services, Johnson & Johnson JJDC, Orion Partners (Hong Kong), and Rüd, Blass & Cie AG are 5 of 6 investors who have invested in Maxia Pharmaceuticals.
-
When was Maxia Pharmaceuticals acquired?
Maxia Pharmaceuticals was acquired on 19-Feb-2003.
-
Who acquired Maxia Pharmaceuticals?
Maxia Pharmaceuticals was acquired by Incyte.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
